CStone Pharmaceuticals (CSPHF)
USD 0.52
(0.0%)
USD 0.52
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.2 Billion CNY | 1.35% |
| 2022 | 1.18 Billion CNY | 11.71% |
| 2021 | 1.06 Billion CNY | 31.69% |
| 2020 | 808.29 Million CNY | 72.32% |
| 2019 | 469.06 Million CNY | -58.0% |
| 2018 | 1.11 Billion CNY | 886.32% |
| 2017 | 113.22 Million CNY | 91.32% |
| 2016 | 59.18 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.06 Billion CNY | 0.0% |
| 2024 Q1 | 1.06 Billion CNY | -11.68% |
| 2023 Q3 | 1.2 Billion CNY | 14.12% |
| 2023 FY | 1.2 Billion CNY | 1.35% |
| 2023 Q1 | 1.05 Billion CNY | -11.19% |
| 2023 Q4 | 1.2 Billion CNY | 0.0% |
| 2023 Q2 | 1.05 Billion CNY | 0.0% |
| 2022 Q1 | 1.06 Billion CNY | -0.03% |
| 2022 Q4 | 1.18 Billion CNY | 0.0% |
| 2022 Q2 | 1.06 Billion CNY | 0.0% |
| 2022 FY | 1.18 Billion CNY | 11.71% |
| 2022 Q3 | 1.18 Billion CNY | 11.75% |
| 2021 Q1 | 558.34 Million CNY | -30.92% |
| 2021 FY | 1.06 Billion CNY | 31.69% |
| 2021 Q4 | 1.06 Billion CNY | 0.0% |
| 2021 Q3 | 1.06 Billion CNY | 90.64% |
| 2021 Q2 | 558.34 Million CNY | 0.0% |
| 2020 Q2 | 378.86 Million CNY | 0.0% |
| 2020 Q1 | 378.86 Million CNY | -19.23% |
| 2020 FY | 808.29 Million CNY | 72.32% |
| 2020 Q4 | 808.29 Million CNY | 0.0% |
| 2020 Q3 | 808.29 Million CNY | 113.35% |
| 2019 Q3 | 457.96 Million CNY | 383.16% |
| 2019 FY | 469.06 Million CNY | -58.0% |
| 2019 Q2 | 94.78 Million CNY | 0.0% |
| 2019 Q1 | 94.78 Million CNY | -91.51% |
| 2019 Q4 | 469.06 Million CNY | 2.42% |
| 2018 Q4 | 1.11 Billion CNY | 63.57% |
| 2018 FY | 1.11 Billion CNY | 886.32% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 Q3 | 682.75 Million CNY | 0.0% |
| 2017 Q4 | 113.22 Million CNY | 0.0% |
| 2017 FY | 113.22 Million CNY | 91.32% |
| 2016 FY | 59.18 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -4393036.004% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -1942.173% |
| Neon Bloom, Inc. | 1.22 Million USD | -98183.822% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -148908.153% |
| Qrons Inc. | 1.48 Million USD | -80853.75% |
| Regen BioPharma, Inc. | 5.45 Million USD | -21982.334% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -1562.967% |
| BioStem Technologies, Inc. | 15.9 Million USD | -7477.455% |
| Skye Bioscience, Inc. | 14.07 Million USD | -8464.166% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -2696268.803% |
| Rebus Holdings, Inc. | 5.24 Million USD | -22890.633% |
| CSL Limited | 18.62 Billion USD | 93.528% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -1508.608% |
| Capstone Therapeutics Corp. | 50.26 Million USD | -2297.678% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -599140.737% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -12631.661% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -2160.893% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -12477.398% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -285777.723% |
| SQZ Biotechnologies Company | 50.03 Million USD | -2308.459% |
| Intellipharmaceutics International Inc. | 12 Million USD | -9935.743% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -31191.517% |
| Mesoblast Limited | 188.44 Million USD | -539.535% |
| Marizyme, Inc. | 26.67 Million USD | -4417.851% |
| Genus plc | 485 Million USD | -148.488% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -20527.198% |
| Pharming Group N.V. | 244.07 Million USD | -393.774% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -59854.779% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -47793.955% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -31614.974% |
| ContraFect Corporation | 32.53 Million USD | -3604.679% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -60726.939% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -31385.889% |
| IMV Inc. | 37.93 Million USD | -3077.116% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -10132.205% |
| MultiCell Technologies, Inc. | 1617.67 USD | -74500199.814% |
| ONE Bio Corp. | 27.49 Million USD | -4283.101% |
| Accustem Sciences Inc. | 1.07 Million USD | -111568.407% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -1456.724% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -56880.127% |
| Q BioMed Inc. | 8.13 Million USD | -14718.37% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | -1353.149% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -23319.37% |
| Biomind Labs Inc. | 1.49 Million USD | -80319.014% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | -915.117% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -13228.281% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -6448.616% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -83950.616% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -848043.144% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -20874.705% |
| GB Sciences, Inc. | 5.41 Million USD | -22145.617% |
| Alpha Cognition Inc. | 7.16 Million USD | -16720.754% |
| HST Global, Inc. | 593.59 Thousand USD | -202929.517% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -95609.633% |
| Halberd Corporation | 728.71 Thousand USD | -165281.855% |
| Enzolytics Inc. | 365.26 Million USD | -229.94% |
| Agentix Corp. | 2.51 Million USD | -47904.087% |
| Resverlogix Corp. | 67.39 Million USD | -1688.191% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -143589.403% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | -170.854% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -70213.244% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -4770.151% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -10024.832% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -32781.721% |
| AVAX Technologies, Inc. | 3.99 Million USD | -30076.413% |
| Zenith Capital Corp. | 27.56 Thousand USD | -4371364.326% |
| Genscript Biotech Corporation | 1.32 Billion USD | 9.104% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -504885.879% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -32172.904% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -176913.633% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -44344.268% |
| Kadimastem Ltd | 3.5 Million USD | -34285.584% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -1800567.872% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -259244.005% |
| LadRx Corporation | 2.2 Million USD | -54667.265% |
| Cell Source, Inc. | 15.8 Million USD | -7524.412% |
| Regen BioPharma, Inc. | 5.45 Million USD | -21982.334% |
| NovAccess Global Inc. | 7.86 Million USD | -15231.511% |
| Affymax, Inc. | 8.87 Million USD | -13485.492% |
| Itoco Inc. | 1.65 Million USD | -72801.326% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -58643.886% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -19823.442% |
| Mobile Lads Corp. | 1.31 Million USD | -91652.703% |
| CytoDyn Inc. | 127.89 Million USD | -842.319% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -2883148.403% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -76839.907% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -10811.159% |
| SYBLEU INC | 681.41 Thousand USD | -176763.224% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -19650.701% |
| International Stem Cell Corporation | 5.27 Million USD | -22738.147% |
| Bioxytran, Inc. | 3.24 Million USD | -36987.829% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -192477.767% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -26002.152% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -2839.723% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -5312.841% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -59403.147% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -21900.164% |
| Neutra Corp. | 973.52 Thousand USD | -123693.847% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -4053.607% |
| PureTech Health plc | 125.58 Million USD | -859.659% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -31976.894% |
| IXICO plc | 1.9 Million USD | -63320.201% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -5770.568% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -1066.398% |
| CSL Limited | 18.62 Billion USD | 93.528% |
| Cellectis S.A. | 249.36 Million USD | -383.287% |